Through this platform, we facilitate the discovery, optimization and pre-clinical evaluation of drug candidates, as well as the advancement of clinical development for investigational drugs.

Leveraging our insights into inflammatory responses and immune regulation, our first-in class drug pipeline is focused on targeting multiple mechanisms with a single molecule to exert a synergistic effect on various indications with significant unmet medical needs and substantial global market potential.

The pipeline covers variety of therapies for the treatment of oncology, ophthalmology, and respiratory diseases etc.

• Tumor Immunotherapy
• Ophthalmology
• Pulmonary Fibrosis
• CNS
• Auto-Immune Diseases